Table 6.
Dimension | Items |
T1 → T2_R
a
|
T1 → T3_R
b
|
T3 → T4_R
c
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
N | τ | p | N | τ | p | N | τ | p | ||
QLQ-C30 |
|
|
|
|
|
|
|
|
|
|
Physical functioning |
1 – 4d |
100 |
-0.02 |
0.858 |
139 |
0.27 |
0.004 |
201 |
-0.84 |
<0.001 |
Role functioning |
6, 7 |
84 |
0.36e |
0.011 |
118 |
0.71 |
<0.001 |
164 |
-0.60 |
<0.001 |
Emotional functioning |
21 - 24 |
180 |
-0.62 |
<0.001 |
208 |
-0.65 |
<0.001 |
196 |
0.22 |
<0.001 |
Cognitive functioning |
20, 25 |
103 |
-1.15 |
<0.001 |
129 |
-0.29 |
0.020 |
130 |
-0.53 |
<0.001 |
Social functioning |
26, 27 |
75 |
0.07 |
0.791 |
101 |
0.66 |
<0.001 |
142 |
-0.51 |
<0.001 |
Fatigue |
10, 12, 18 |
141 |
-0.19 |
0.280 |
160 |
0.23 |
0.019 |
183 |
-0.99 |
<0.001 |
Nausea and vomiting |
14, 15 |
37 |
-0.60 |
0.022 |
65 |
0.50 |
0.029 |
98 |
-0.36 |
0.003 |
Pain |
9, 19 |
96 |
0.11 |
0.410 |
124 |
0.37 |
0.001 |
148 |
-0.54 |
<0.001 |
Dyspnea |
8 |
50 |
-0.60 |
0.025 |
55 |
-0.30 |
0.248 |
94 |
-0.42 |
0.014 |
Insomnia |
11 |
115 |
-0.49 |
0.001 |
135 |
-0.49 |
<0.001 |
147 |
-0.36 |
0.005 |
Appetite loss |
13 |
61 |
-0.59 |
0.004 |
85 |
-0.14 |
0.401 |
90 |
-0.51 |
0.003 |
Constipation |
16 |
71 |
-0.16 |
0.392 |
89 |
0.17 |
0.295 |
93 |
-0.41 |
0.009 |
Diarrhea |
17 |
39 |
-1.34 |
<0.001 |
64 |
-0.67 |
0.005 |
61 |
-0.09 |
0.641 |
Financial difficulties |
28 |
22 |
0.16 |
0.630 |
33 |
0.25 |
0.322 |
47 |
-0.45 |
0.053 |
QLQ-BR23 |
|
|
|
|
|
|
|
|
|
|
Body image |
9 - 12 |
68 |
0.10 |
0.489 |
119 |
0.83 |
<0.001 |
153 |
-0.66 |
<0.001 |
Sexual functioning |
14, 15 |
55 |
0.06 |
0.950 |
71 |
0.33 |
0.078 |
78 |
0.77 |
0.010 |
Sexual enjoyment |
16 |
13 |
-1.20 |
0.04 |
39 |
-0.43 |
0.14 |
33 |
0.19 |
0.49 |
Future perspective |
13 |
122 |
-0.56 |
<0.01 |
135 |
-0.46 |
<0.01 |
144 |
0.01 |
0.95 |
STSE |
1 - 4; 6 - 8 |
55 |
-0.40 |
<0.01 |
61 |
0.21 |
0.013 |
77 |
-0.74 |
<0.001 |
Breast symptoms |
20 - 23 |
114 |
-0.11 |
0.07 |
135 |
0.36 |
0.01 |
190 |
-0.76 |
<0.001 |
Arm symptoms |
17 - 19 |
97 |
0.64 |
<0.001 |
167 |
0.86 |
<0.001 |
156 |
-0.37 |
0.001 |
Hair loss | Q5 | 6 | 0.22 | 0.738 | 16 | 0.12 | 0.808 | 24 | -0.33 | 0.149 |
aT1 → T2_R: comparison of baseline quality of life assessment and retrospective measure performed after surgery.
bT1 → T3_R: comparison of baseline quality of life assessment and retrospective measure performed three months later.
cT3 → T4_R: comparison of quality of life assessment at three months and retrospective measure performed three months later.
dQ5 was excluded because of the patients’ responses to this item at baseline: all patients chose either category 1 or 2 for this item at baseline, whereas all four categories were represented on retrospective measures.
eτ =0.364: patients significantly chose higher response categories at the retrospective measure of baseline HRQoL performed after surgery.